>MIT did not renew their contract with Elsevier in 2020, a major reason being their inequitable profit model, and refusal to honor open access agreements. They have a postmortem saying the loss had little impact to their researchers.
This "fact" about MIT cancelling the Elsevier subscription is often cited but in isolation, it's misleading because it makes seem like MIT students and faculty don't even need Elsevier articles. That's not true.
MIT in providing some other access methods to the same Elsevier articles for their researchers -- at the cost of some extra inconvenient steps -- is actually proving the opposite of the anti-publisher stance: The Elsevier publisher's articles are still valuable to us.
It's the subscription they cancelled and not the articles.
> It's the subscription they cancelled and not the articles.
Correct. Before the UC system also cancelled their subscription with Elsevier they reported paying $11 million annually.
> The Elsevier publisher's articles are still valuable to us.
Yes, but not $11 million/year with a 3 year lock-in. UC reported (at the time of ending the contract) that they have a perpetual license to ~95% of relevant work on Elsevier, so that $11 million/year went to access 5% of Elsevier's library.
What we do see is publishers shifting to open access (OA), which appears to result in lower Uni costs, but shifts the expense burden to researchers. Researchers in the UC system are now asked to use grant funding to help pay OA APC fees.
This "fact" about MIT cancelling the Elsevier subscription is often cited but in isolation, it's misleading because it makes seem like MIT students and faculty don't even need Elsevier articles. That's not true.
What happened is that MIT switched to a pay-per-article or library loan method: https://libraries.mit.edu/scholarly/publishing/how-to-access...
MIT in providing some other access methods to the same Elsevier articles for their researchers -- at the cost of some extra inconvenient steps -- is actually proving the opposite of the anti-publisher stance: The Elsevier publisher's articles are still valuable to us.
It's the subscription they cancelled and not the articles.